What is HC Wainwright's Estimate for AMPX Q1 Earnings?

Key Points

• HC Wainwright analyst A. Dayal forecasts Amprius (NYSE:AMPX) will earn ($0.02) EPS in Q1 2026 (the firm's full-year consensus is ($0.45) per share).
• Amprius recently beat Q4 expectations with ($0.01) EPS vs. a ($0.04) estimate and $25.23M revenue, reported its first positive adjusted EBITDA, and set 2026 guidance targeting at least $125M in revenue—driving analyst upgrades and a notable stock rally.
• Analyst sentiment is largely bullish (eight Buys vs. one Sell) with a consensus price target of $18.38, though insiders sold sizable positions last quarter and the company remains unprofitable on a GAAP basis.

Amprius Technologies, Inc. (NYSE:AMPX - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Amprius Technologies in a research note issued to investors on Friday, March 6th. HC Wainwright analyst A. Dayal expects that the company will earn ($0.02) per share for the quarter. The consensus estimate for Amprius Technologies' current full-year earnings is ($0.45) per share. HC Wainwright also issued estimates for Amprius Technologies' Q2 2026 earnings at ($0.02) EPS, Q3 2026 earnings at ($0.01) EPS, Q4 2026 earnings at $0.00 EPS, FY2029 earnings at $0.35 EPS and FY2030 earnings at $0.55 EPS.

AMPX has been the subject of a number of other reports. William Blair reiterated an "outperform" rating on shares of Amprius Technologies in a report on Friday. Weiss Ratings reissued a "sell (e+)" rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Needham & Company LLC initiated coverage on Amprius Technologies in a research note on Thursday, January 29th. They issued a "buy" rating and a $20.00 target price for the company. Craig Hallum increased their price target on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a "buy" rating in a research report on Friday. Finally, Roth Mkm reissued a "buy" rating and set a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a research note on Friday. Eight analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $18.38.

Amprius Technologies Stock Up 9.9%

AMPX opened at $16.37 on Monday. The business's fifty day simple moving average is $10.88 and its 200 day simple moving average is $10.75. Amprius Technologies has a 52 week low of $1.70 and a 52 week high of $17.29. The stock has a market cap of $2.14 billion, a PE ratio of -48.15 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 25.77%. The firm had revenue of $25.23 million for the quarter, compared to analysts' expectations of $22.91 million. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS.

Insider Activity

In other news, CTO Constantin Ionel Stefan sold 492,827 shares of the business's stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total value of $5,933,637.08. Following the completion of the sale, the chief technology officer owned 748,696 shares of the company's stock, valued at approximately $9,014,299.84. The trade was a 39.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kang Sun sold 950,548 shares of the stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $11.07, for a total value of $10,522,566.36. Following the sale, the director owned 1,403,651 shares of the company's stock, valued at $15,538,416.57. This represents a 40.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 2,392,269 shares of company stock worth $26,384,359. Company insiders own 12.80% of the company's stock.

Institutional Trading of Amprius Technologies

A number of institutional investors have recently made changes to their positions in the stock. Bank of America Corp DE grew its holdings in shares of Amprius Technologies by 31.1% in the fourth quarter. Bank of America Corp DE now owns 12,890 shares of the company's stock worth $36,000 after purchasing an additional 3,055 shares during the last quarter. Ameritas Investment Partners Inc. raised its holdings in Amprius Technologies by 2,043.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company's stock valued at $40,000 after buying an additional 9,072 shares during the last quarter. Quarry LP purchased a new stake in Amprius Technologies during the 3rd quarter valued at $42,000. Rhumbline Advisers grew its holdings in Amprius Technologies by 61.1% in the 1st quarter. Rhumbline Advisers now owns 15,690 shares of the company's stock worth $42,000 after acquiring an additional 5,951 shares during the last quarter. Finally, Legal & General Group Plc grew its holdings in Amprius Technologies by 1,385.4% in the 2nd quarter. Legal & General Group Plc now owns 10,383 shares of the company's stock worth $44,000 after acquiring an additional 9,684 shares during the last quarter. Hedge funds and other institutional investors own 5.04% of the company's stock.

Amprius Technologies News Roundup

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Q4 2025 results beat expectations — revenue of ~$25.2M (137% YoY), a smaller-than-expected loss, the company's first positive quarterly adjusted EBITDA, and 2026 guidance targeting at least $125M in revenue and a materially reduced net loss. This combination explains the bullish sentiment and supports growth expectations. Amprius Technologies (AMPX) Is Up 29.3% After Issuing 2026 Revenue And Profitability Guidance - Has The Bull Case Changed?
• Positive Sentiment: Analyst upgrades and higher price targets: Roth MKM reaffirmed a Buy and bumped its PT to $20 (from $16), and Craig-Hallum raised its PT to $21 (from $17). Upgrades add credibility and can attract more institutional flows. Benzinga Craig-Hallum PT Raised to $21
• Positive Sentiment: Institutional interest, analyst coverage and bullish research notes (MarketBeat et al.) are increasing — analysts are raising targets and coverage, which can amplify momentum and reduce float available to retail sellers. Amprius Stock Price Gets Amped by Hyper Growth Outlook
• Positive Sentiment: Derivative and volume signals: unusually large call-option volume and heavy share trading indicate speculative and directional conviction from traders, which can accelerate short-term gains. (Observed trading activity reported on 3/5.)
• Neutral Sentiment: One-time charge for a discontinued Colorado lease was disclosed; management frames it as a non-recurring item that clarifies manufacturing strategy (shift to contract manufacturers) and improves cash-flow visibility. That reduces future capex needs but creates a near-term hit. Amprius Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results
• Neutral Sentiment: Media/analyst pieces debating valuation and timing — several write-ups ask if the rally already prices in most of the upside, prompting mixed views among longer-term investors. These discussions can increase volatility as momentum and value investors clash. Is It Too Late To Consider Amprius Technologies (AMPX) After Its Recent Share Price Surge
• Negative Sentiment: Company remains unprofitable on a GAAP basis (full-year net loss and negative margins); analysts still forecast negative EPS for the year. Continued execution is required to translate revenue growth into sustained profitability — a risk that could weigh on the stock if growth or margin improvement stalls. Amprius Technologies (AMPX) Reports Q4 Loss, Tops Revenue Estimates

About Amprius Technologies

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.